Brief: Suven Life Sciences secures process patents in Europe, Japan and New Zealand
Aug 17 (Reuters) - Suven Life Sciences Ltd SUVP.NS :
* Secures process patents in Europe, Japan and New Zealand
* Patents for new chemical entities for treatment of
disorders associated with neurodegenerative diseases
Source text: (http://bit.ly/2vKB7xV)
Further company coverage: SUVP.NS
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Suven Life Sciences
See all newsBrief: Suven Life Sciences Completes Phase-1 Study Of SUVN-I6107, Advances To Phase-2
Brief: Suven Life Sciences Reports Positive DSMB Safety Review For Phase-3 Masupirdine Study
Brief: Suven Life Sciences Records 100% Patient Enrolment Milestone In Phase-2B Clinical Trial Of Ropanicant
Brief: Suven Life Sciences Says First Patient Randomized In Phase-2B Clinical Trial Of Ropanicant
Brief: Suven Life Sciences March-Quarter Consol Net Loss 439.4 Million Rupees